16320 related articles for article (PubMed ID: 34964106)
21. Legal and Policy Considerations in Lebanon Related to Proposals for Paraphilic Disorders in World Health Organization's International Classification of Diseases Manual, 11th Version.
Makhlouf Y; Kerbage H; Khauli N; Ramadan Z; Khoury B
J Sex Med; 2020 Mar; 17(3):491-504. PubMed ID: 31953030
[TBL] [Abstract][Full Text] [Related]
22. Bipolar II disorder : epidemiology, diagnosis and management.
Benazzi F
CNS Drugs; 2007; 21(9):727-40. PubMed ID: 17696573
[TBL] [Abstract][Full Text] [Related]
23. Bipolar disorders in the new DSM-5 and ICD-11 classifications.
de Dios C; Goikolea JM; Colom F; Moreno C; Vieta E
Rev Psiquiatr Salud Ment; 2014; 7(4):179-85. PubMed ID: 25450512
[TBL] [Abstract][Full Text] [Related]
24. French antecedents of "contemporary" concepts in the American Psychiatric Association's classification of bipolar (mood) disorders.
Haustgen T; Akiskal H
J Affect Disord; 2006 Dec; 96(3):149-63. PubMed ID: 17092563
[TBL] [Abstract][Full Text] [Related]
25. Comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis.
Mezei G; Chang ET; Mowat FS; Moolgavkar SH
Scand J Work Environ Health; 2021 Jan; 47(1):85-86. PubMed ID: 32626907
[TBL] [Abstract][Full Text] [Related]
26. Toward a clinical delineation of dysphoric hypomania - operational and conceptual dilemmas.
Akiskal HS; Benazzi F
Bipolar Disord; 2005 Oct; 7(5):456-64. PubMed ID: 16176439
[TBL] [Abstract][Full Text] [Related]
27. Gender, temperament, and the clinical picture in dysphoric mixed mania: findings from a French national study (EPIMAN).
Akiskal HS; Hantouche EG; Bourgeois ML; Azorin JM; Sechter D; Allilaire JF; Lancrenon S; Fraud JP; Châtenet-Duchêne L
J Affect Disord; 1998 Sep; 50(2-3):175-86. PubMed ID: 9858077
[TBL] [Abstract][Full Text] [Related]
28. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
29. [Alpha-interferon and mental disorders].
Debien C; De Chouly De Lenclave MB; Foutrein P; Bailly D
Encephale; 2001; 27(4):308-17. PubMed ID: 11686052
[TBL] [Abstract][Full Text] [Related]
30. Challenges and Strategies for Current Classifications of Depressive Disorders: Proposal for Future Diagnostic Standards.
Park SC; Kim YK
Adv Exp Med Biol; 2021; 1305():103-116. PubMed ID: 33834397
[TBL] [Abstract][Full Text] [Related]
31. Clinical characterization of depressive mixed state in bipolar-I patients: Pisa-San Diego collaboration.
Perugi G; Akiskal HS; Micheli C; Toni C; Madaro D
J Affect Disord; 2001 Dec; 67(1-3):105-14. PubMed ID: 11869757
[TBL] [Abstract][Full Text] [Related]
32. [Diagnostic structured interviews in child and adolescent's psychiatry].
Renou S; Hergueta T; Flament M; Mouren-Simeoni MC; Lecrubier Y
Encephale; 2004; 30(2):122-34. PubMed ID: 15107714
[TBL] [Abstract][Full Text] [Related]
33. Mixed features in bipolar disorder.
Solé E; Garriga M; Valentí M; Vieta E
CNS Spectr; 2017 Apr; 22(2):134-140. PubMed ID: 28031070
[TBL] [Abstract][Full Text] [Related]
34. Evaluating depressive symptoms in hypomanic and manic episodes using a structured diagnostic tool: validation of a new Mini International Neuropsychiatric Interview (M.I.N.I.) module for the DSM-5 'With Mixed Features' specifier.
Hergueta T; Weiller E
Int J Bipolar Disord; 2013; 1():21. PubMed ID: 25505685
[TBL] [Abstract][Full Text] [Related]
35. [Early intervention in bipolar affective disorders: Why, when and how].
Pouchon A; Fakra E; Haesebaert F; Legrand G; Rigon M; Schmitt E; Conus P; Bougerol T; Polosan M; Dondé C
Encephale; 2022 Feb; 48(1):60-69. PubMed ID: 34565543
[TBL] [Abstract][Full Text] [Related]
36. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
Foffi G; Pastore A; Piazza F; Temussi PA
Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
[TBL] [Abstract][Full Text] [Related]
37. Issues on the diagnosis and etiopathogenesis of mood disorders: reconsidering DSM-5.
Ogasawara K; Nakamura Y; Kimura H; Aleksic B; Ozaki N
J Neural Transm (Vienna); 2018 Feb; 125(2):211-222. PubMed ID: 29275445
[TBL] [Abstract][Full Text] [Related]
38. Does the FDA proposed list of possible correlates of suicidality associated with antidepressants apply to an adult private practice population?
Akiskal HS; Benazzi F
J Affect Disord; 2006 Aug; 94(1-3):105-10. PubMed ID: 16766043
[TBL] [Abstract][Full Text] [Related]
39. The prevalence and illness characteristics of DSM-5-defined "mixed feature specifier" in adults with major depressive disorder and bipolar disorder: Results from the International Mood Disorders Collaborative Project.
McIntyre RS; Soczynska JK; Cha DS; Woldeyohannes HO; Dale RS; Alsuwaidan MT; Gallaugher LA; Mansur RB; Muzina DJ; Carvalho A; Kennedy SH
J Affect Disord; 2015 Feb; 172():259-64. PubMed ID: 25451425
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
